Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zahava Vadasz

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Biology|February 6, 2021
Expression of Semaphorin 3A in Malignant and Normal Bladder Tissue: Immunohistochemistry Staining and Morphometric EvaluationIlan Bejar, Jacob Rubinstein, Jacob Bejar, et al.
Seminars in Arthritis and Rheumatism|January 28, 2014
A regulatory role for CD72 expression on B cells in systemic lupus erythematosusZahava Vadasz, Tharwat Haj, Alexandra Balbir, et al.
Pediatric Surgery International|December 6, 2005
Effect of leptin on intestinal re-growth following massive small bowel resection in ratIgor Sukhotnik, Zahava Vadasz, Arnold G Coran, et al.
Frontiers in Pediatrics|December 12, 2022
Favorable outcome of empagliflozin treatment in two pediatric glycogen storage disease type 1b patientsZufit Hexner-Erlichman, Maria Veiga-da-Cunha, Yoav Zehavi, et al.
Clinical and Experimental Rheumatology|May 10, 2016
Semaphorin 3A, a potential immune regulator in familial Mediterranean feverDoron Rimar, Itzhak Rosner, Gleb Slobodin, et al.
Harefuah|August 9, 2017
[THE ROLE OF SEMAPHORIN 7A IN SYSTEMIC SCLEROSIS]Doron Rimar, Gleb Slobodin, Itzhak Rosner, et al.
International Journal of Molecular Sciences|November 27, 2025
Semaphorin3A Rewires CD4<sup>+</sup> T-Cell Metabolism via AKT/mTORC1 Inhibition in Health and Rheumatoid ArthritisRaeda Mubariki, Nasren Eiza, Adi D Sabag, et al.
Frontiers in Immunology|April 11, 2019
Semaphorin 3A Is Effective in Reducing Both Inflammation and Angiogenesis in a Mouse Model of Bronchial AsthmaSabag D Adi, Nasren Eiza, Jacob Bejar, et al.
The Israel Medical Association Journal : IMAJ|June 5, 2015
Interferon-gamma-release assay prevents unnecessary tuberculosis therapyVered Schichter-Konfino, Katalin Halasz, Galia Grushko, et al.
Arthritis Research & Therapy|June 16, 2012
Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosusZahava Vadasz, Tharwat Haj, Katalin Halasz, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Biology|February 6, 2021
Expression of Semaphorin 3A in Malignant and Normal Bladder Tissue: Immunohistochemistry Staining and Morphometric EvaluationIlan Bejar, Jacob Rubinstein, Jacob Bejar, et al.
Seminars in Arthritis and Rheumatism|January 28, 2014
A regulatory role for CD72 expression on B cells in systemic lupus erythematosusZahava Vadasz, Tharwat Haj, Alexandra Balbir, et al.
Pediatric Surgery International|December 6, 2005
Effect of leptin on intestinal re-growth following massive small bowel resection in ratIgor Sukhotnik, Zahava Vadasz, Arnold G Coran, et al.
Frontiers in Pediatrics|December 12, 2022
Favorable outcome of empagliflozin treatment in two pediatric glycogen storage disease type 1b patientsZufit Hexner-Erlichman, Maria Veiga-da-Cunha, Yoav Zehavi, et al.
Clinical and Experimental Rheumatology|May 10, 2016
Semaphorin 3A, a potential immune regulator in familial Mediterranean feverDoron Rimar, Itzhak Rosner, Gleb Slobodin, et al.
Harefuah|August 9, 2017
[THE ROLE OF SEMAPHORIN 7A IN SYSTEMIC SCLEROSIS]Doron Rimar, Gleb Slobodin, Itzhak Rosner, et al.
International Journal of Molecular Sciences|November 27, 2025
Semaphorin3A Rewires CD4<sup>+</sup> T-Cell Metabolism via AKT/mTORC1 Inhibition in Health and Rheumatoid ArthritisRaeda Mubariki, Nasren Eiza, Adi D Sabag, et al.
Frontiers in Immunology|April 11, 2019
Semaphorin 3A Is Effective in Reducing Both Inflammation and Angiogenesis in a Mouse Model of Bronchial AsthmaSabag D Adi, Nasren Eiza, Jacob Bejar, et al.
The Israel Medical Association Journal : IMAJ|June 5, 2015
Interferon-gamma-release assay prevents unnecessary tuberculosis therapyVered Schichter-Konfino, Katalin Halasz, Galia Grushko, et al.
Arthritis Research & Therapy|June 16, 2012
Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosusZahava Vadasz, Tharwat Haj, Katalin Halasz, et al.
Pageof 7